戻る
Immuron Ltd (IMRN)価格
IMRN 株価推移チャート
IMRN 収入
Immuron Ltd
$1.06
-0.93%
$-0.01
終値： Jan 16, 16:00:00 GMT-5
$1.1
3.77%
$0.04
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$1.07
始値
$1.05
当日レンジ
$1.05 - $1.13
52週レンジ
$0.677 - $2.39
取引高
54.0K
平均取引高
571.3K
1株当たり利益(TTM)
-0.60
配当利回り
--
時価総額
$8.8M
IMRNとは何ですか？
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), and IMM-529.